logo
  

TP ICAP First Quarter Revenue Down 9%

TP ICAP (IAPLF.PK,IAPLY.PK,IAP.L) Wednesday reported a 9 percent decline in first-quarter revenue on a constant currency basis to 483 million pounds, compared to 530 million in the prior year. On a reported basis, revenue was down 12 percent from the last year. The company said the results were impacted by extreme volatility across all asset classes.

The diversified global markets infrastructure and data solutions provider projected low single digit revenue growth for the full year, excluding Liquidnet revenues.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Mallinckrodt plc announced Wednesday that the U.S. Food and Drug Administration or FDA has approved StrataGraft (allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen - dsat) for the treatment of adult patients with thermal burns containing intact dermal elements for which surgical intervention is clinically indicated. Worldwide 5G mobile subscriptions are estimated to exceed 580 million by the end of 2021, according to the Ericsson Mobility Report. With subscriptions increasing at a rate of about a million per day, 5G remains on track to become the fastest adopted mobile generation in history. The growth in subscriptions is being lead by China, North America and the Gulf Cooperation Council markets. Elanco Animal Health Inc. (ELAN) and veterinary biopharmaceutical company Kindred Biosciences, Inc. (KIN) announced Wednesday they have entered into a definitive agreement for Elanco to acquire Kindred for $9.25 per share, or approximately $440 million. The acquisition further accelerates Elanco's...
RELATED NEWS
Follow RTT